New inhaled treatment tested for serious lung pressure disease
NCT ID NCT04691154
Summary
This study is testing the safety and side effects of an inhaled medication called L606 for adults with pulmonary hypertension, a serious condition where blood pressure is too high in the lungs. The trial follows 28 patients for up to a year to see how well they tolerate switching to or starting this twice-daily inhaled treatment. Researchers want to understand both short-term and long-term safety for people with two types of this condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arizona Pulmonary Specialists
Scottsdale, Arizona, 85258, United States
-
Baylor Scott and White Research Institute
Temple, Texas, 76508, United States
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029-6504, United States
-
Mayo Clinic Jacksonville
Jacksonville, Florida, 32224, United States
-
Summit Health Eastside Clinic
Bend, Oregon, 97701, United States
-
University of Cincinnati Medical Center
Cincinnati, Ohio, 45267, United States
-
University of South Florida
Tampa, Florida, 33606, United States
-
VA Greater Los Angeles Healthcare
Los Angeles, California, 90073, United States
Conditions
Explore the condition pages connected to this study.